Agents that Reverse Multidrug Resistance, Tamoxifen, Verapamil, and Cyclosporin A, Block Glycosphingolipid Metabolism by Inhibiting Ceramide Glycosylation in Human Cancer Cells
Open Access
- 1 January 1997
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 272 (3), 1682-1687
- https://doi.org/10.1074/jbc.272.3.1682
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Dual Roles of Sphingolipids in Signaling of the Escape from and Onset of Apoptosis in a Mouse Cytotoxic T-cell Line, CTLL-2Published by Elsevier ,1996
- Sphingolipid Biosynthesis Is Necessary for Dendrite Growth and Survival of Cerebellar Purkinje Cells in CultureJournal of Neurochemistry, 1995
- Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signalsCell, 1995
- Tamoxifen's role in chemoprevention of breast cancer: An updateJournal of Cellular Biochemistry, 1995
- Programmed Cell Death Induced by CeramideScience, 1993
- Sufficient levels of quinine in the serum circumvent the multidrug resistance of the human leukemic cell line K562/ADMCancer, 1991
- Plasma membrane lipid composition of vinblastine sensitive and resistant human leukaemic lymphoblastsInternational Journal of Cancer, 1988
- GD2 ganglioside biosynthesis is a distinct biochemical event in human melanoma tumor progressionFEBS Letters, 1986
- Phospholipid and ether linked phospholipid content alter with cellular resistance to vinblastineBiochemical and Biophysical Research Communications, 1985
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959